BSE filing, NSE: KANPRPLA. Summary written from the filing by ALFA Finder's alert engine.
Kanpur Plastipack Ltd: key numbers
- Share price
- ₹248.32
- Market cap
- ₹610.2 Cr
- Revenue (annual)
- ₹718.8 Cr
- Net profit (annual)
- ₹39.49 Cr
- P/E (TTM)
- 11.4×Sector 45.2×
- Promoter holding
- 68.03%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Kanpur Plastipack Ltd
All →Kanpur Plastipack Earnings Call Transcript: Key Takeaways
Kanpur Plastipack achieved record quarterly revenue despite global headwinds, though profitability was significantly aided by one-time export incentives.
- Call
- Guides 20% growth
Kanpur Plastipack Investor Presentation: Key Takeaways
Q2 FY27 consolidated revenue ₹2,402.2 Mn (+44.2%), EBITDA ₹266.2 Mn (+58.5%), PAT ₹160.6 Mn (+102.1%), EBITDA margin 11.1%. Strategy: FIBC scale-up, Taslan yarn, non-wovens, UK/Italy expansion.
Kanpur Plastipack Results Update
Kanpur Plastipack reported consolidated revenue, EBITDA and PAT growth of about 44%, 59% and 102% year-on-year in Q2 FY27. The company flagged rainfall-related delays to two expansion projects.
Kanpur Plastipack Management Change
Kanpur Plastipack appointed Sanjiv Swarup as an Additional Independent Director effective October 27, 2026. His regularisation for five years will go to shareholders later.
Kanpur Plastipack Q2 FY27 Results: Net Profit ₹16.1 Cr, Up 109.1% YoY
Kanpur Plastipack Ltd reported revenue from operations of ₹236.3 Cr (+43.0% YoY) and net profit of ₹16.1 Cr (+109.1% YoY) for Q2 FY27.
- Key figure
- Net profit ₹16.1 Cr · +109.1% YoY
Kanpur Plastipack Other Announcement
Kanpur Plastipack Limited filed the quarterly compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026.
Other credit rating announcements
All →Epigral Credit Rating
CRISIL revised Epigral's ratings to CRISIL AA/Stable (long-term) and CRISIL A1+ (short-term) on its bank facilities. The action covers Rs.1,050 Crore of rated bank loan facilities.
Mankind Pharma Credit Rating
CRISIL reaffirmed Mankind Pharma's AA+ rating on Rs.2,500 Crore of NCDs and withdrew ratings on Rs.2,500 Crore NCDs and Rs.1,500 Crore commercial paper. The rating action is dated October 29, 2026.
Lloyds Metals & Energy Credit Rating
Crisil Ratings reaffirmed Lloyds Metals' bank facilities at AA/Stable and A1+, with bank limits enhanced to ₹17,112 crore. It assigned AA/Stable to ₹2,400 crore and ₹1,550 crore of NCDs.
Ram Ratna Wires Credit Rating
CARE Ratings assigned and reaffirmed Ram Ratna Wires' bank facility ratings at CARE A-; Positive / CARE A2+ and revised outlook from Stable to Positive. The long-term bank facilities total Rs.1,046.45 Crore, with several facilities enhanced.
Adani Ports & Special Economic Zone Credit Rating
Fitch Ratings affirmed Adani Ports' Long-Term Foreign-Currency IDR and unsecured notes at 'BBB-' with a Stable outlook. The affirmation keeps the existing rating unchanged.
Capri Global Capital Credit Rating
India Ratings affirmed CGCL's credit rating at IND AA- with Positive outlook. A new Rs. 500 Cr bank loan facility was also assigned the same rating.